最新ニュース FormFactor (NASDAQ:FORM) 株価情報

FormFactor

FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

FormFactor Inc

FORMATION METALS INC by FORMATION METALS INC

FORMOSA PROSONIC INDSTS by Formosa Prosonic Industries Bhd

FORMATION MINERALS INC by Formation Minerals, Inc.

Formation Minerals Inc

Formcap Corp

Formidable ETF

Formula Systems (1985) Ltd. - American Depositary Shares

Formula Systems (1985) Ltd

Stifel analyst Brian Chin maintains FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) with a Hold and lowers the price target from $48 to $42.

News

Price Target

Analyst Ratings

FORM

Stifel Maintains Hold on FormFactor, Lowers Price Target to $42

Evercore ISI Group analyst Vedvati Shrotre maintains FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) with a In-Line and lowers the price target from $50 to $43.

Evercore ISI Group Maintains In-Line on FormFactor, Lowers Price Target to $43

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Evercore ISI Group analyst Shweta Khajuria downgraded the rating for Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) from Outperform to In-Line and maintained the price target of $35. Match Group shares closed at $33.58 on Wednesday. <a href="https://www.benzinga.com/quote/MTCH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst Vijay Rakesh downgraded Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) from Outperform to Neutral and lowered the price target from $105 to $62. Skyworks Solutions shares closed at $87.08 on Wednesday. <a href="https://www.benzinga.com/quote/SWKS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Robbie Marcus downgraded CONMED Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) from Overweight to Neutral and cut the price target from $85 to $70. Conmed shares closed at $74.00 on Wednesday. <a href="https://www.benzinga.com/quote/CNMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities analyst Craig Ellis downgraded the rating for FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) from Buy to Neutral and lowered the price target from $64 to $34. FormFactor shares closed at $41.12 on Wednesday. <a href="https://www.benzinga.com/quote/FORM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Alex Scott downgraded Voya Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>) from Overweight to Equal-Weight and maintained the price target of $75. Voya Financial shares closed at $72.22 on Wednesday. <a href="https://www.benzinga.com/quote/VOYA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying MTCH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-1024x576.png" alt="" class="wp-image-769131" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54.png 1106w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

Downgrades

Pre-Market Outlook

Markets

Trading Ideas

CNMD

MTCH

SWKS

VOYA

This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 100 points on Thursday.
Shares of Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) fell sharply in today's pre-market trading after the company said that it expects $5 billion to $5.5 billion in losses in its EV segment this year, in line with the loss <a href="https://www.benzinga.com/tech/25/02/43522408/ford-slides-5-pre-market-after-disappointing-outlook-high-loss-from-ev-segment-in-2024">recorded last year</a>.
Ford said it sees full-year 2025 adjusted EBIT in a range of $7 billion to $8.5 billion, adjusted free cash flow in a range of $3.5 billion to $4.5 billion, and capital spending in a range of $8 billion to $9 billion.
Meanwhile, Ford reported upbeat fourth-quarter financial results on Wednesday.
Ford Motor shares dipped 6.1% to $9.40 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) dipped 29.2% to $61.65 in pre-market trading after the company issued second-quarter adjusted EPS guidance below estimates..</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 27.7% to $29.78 in today's pre-market trading after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued cirst-quarter guidance below estimates.</li>
<li>Matrix Service Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) shares fell 26.1% to $10.38 in pre-market trading after the company reported second-quarter financial results and cut its FY25 sales guidance below estimates.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) fell 18.3% to $6.90 in pre-market trading after the company reported the pricing of $50 million follow-on public offering of class a ordinary shares.   </li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) fell 16.6% to $25.80 in pre-market trading. Symbotic reported quarterly losses of three cents per share which missed the analyst consensus estimate for losses of two cents. Quarterly revenue of $486.69 million also missed the analyst consensus estimate of $490.98 million.</li>
<li>Mach Natural Resources LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) declined 6.9% to $16.00 in pre-market trading as the company announced the launch of 12 million common unit offering.</li>
<li>Mineralys Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) fell 5.5% to $9.70 in pre-market trading. Mineralys Therapeutics will report its financial results from the fourth quarter, before the opening bell on Wednesday, Feb. 12.</li>
<li>Hologic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) slipped 4.9% to $69.22 in pre-market trading following quarterly results.</li>
<li>QUALCOMM Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) fell 4.7% to $167.50 in pre-market trading following first-quarter results.</li>
<li>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) fell 4.2% to $166.06 in pre-market trading. Arm Holdings reported better-than-expected third-quarter financial results for fiscal year 2025 after the market closed on Wednesday. Arm said it expects fourth-quarter revenue of $1.175 billion to $1.275 billion. The company anticipates fourth-quarter adjusted earnings of 48 cents to 56 cents per share. The company also narrowed its full-year guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

Movers

HOLX

MLYS

MTRX

QCOM

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Needham analyst Charles Shi reiterates FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on FormFactorto Hold

<h3>Gainers</h3>
<ul>
<li>Digital Turbine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) shares rose 26.4% to $3.21 during Thursday's pre-market session. The market value of their outstanding shares is at $332.9 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) shares rose 13.31% to $102.1. The market value of their outstanding shares is at $15.7 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock moved upwards by 9.63% to $0.09. The company's market cap stands at $1.9 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock rose 9.3% to $0.3. The company's market cap stands at $7.7 million. </li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) stock rose 8.42% to $7.59. The company's market cap stands at $86.1 million. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares moved upwards by 7.69% to $0.42. The market value of their outstanding shares is at $15.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) stock decreased by 29.5% to $61.4 during Thursday's pre-market session. The market value of their outstanding shares is at $9.8 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) stock declined by 28.75% to $29.3. The market value of their outstanding shares is at $2.2 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) shares declined by 23.66% to $97.0. The market value of their outstanding shares is at $2.7 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alpha &amp; Omega (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) shares decreased by 12.84% to $37.77. The company's market cap stands at $1.0 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) shares fell 5.49% to $2.24. The company's market cap stands at $29.5 million. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) stock declined by 5.31% to $7.85. The market value of their outstanding shares is at $114.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRG

AMOD

AOSL

APPS

BNAI

COHR

CSAI

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Shares of Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) rose sharply in pre-market trading after the company reported <a href="https://www.benzinga.com/quote/COHR/earnings">better-than-expected second-quarter financial results.</a>
Coherent reported quarterly earnings of 95 cents per share which beat the analyst consensus estimate of 69 cents per share.&nbsp; The company reported quarterly sales of $1.44 billion which beat the analyst consensus estimate of $1.37 billion.
Coherent shares jumped 15.5% to $104.04 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) gained 43.5% to $0.6031 in pre-market trading.</li>
<li>Rani Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) rose 28.5% to $1.85 in pre-market trading after the company announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the glucagon-like peptide-1 receptor agonist semaglutide administered via the RaniPill capsule.</li>
<li>Digital Turbine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) gained 28% to $3.25 in pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance.</li>
<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) gained 20.7% to $0.2560 in pre-market trading after gaining around 4% on Wednesday.</li>
<li>Moleculin Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares jumped 20% to $1.20 in pre-market trading after dipping 20% on Wednesday.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) gained 15.2% to $1.58 in pre-market trading after gaining 10% on Wednesday.</li>
<li>Recursion Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) shares climbed 15% to $9.11 in pre-market trading after the company reported 12 month data from phase 2 study (Sycamore) of REC-994 at International Stroke Conference.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 10.3% to $7.84. BigBear.Ai shares jumped 45% on Wednesday after the company announced a contract by the DOD&#8217;s chief digital and artificial intelligence office.</li>
<li>Ginkgo Bioworks Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) gained 8.4% to $17.74 in pre-market trading after climbing over 14% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares fell 29.4% to $0.3950 in pre-market trading.</li>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) dipped 29.2% to $61.65 in pre-market trading after the company issued second-quarter adjusted EPS guidance below estimates..</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 27.7% to $29.78 in today's pre-market trading after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued cirst-quarter guidance below estimates.</li>
<li>Matrix Service Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) shares fell 26.1% to $10.38 in pre-market trading after the company reported second-quarter financial results and cut its FY25 sales guidance below estimates.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares tumbled 19.5% to $0.29 in pre-market trading following a 5% gain on Wednesday.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) fell 18.3% to $6.90 in pre-market trading after the company reported the pricing of $50 million follow-on public offering of class a ordinary shares.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) fell 16.6% to $25.80 in pre-market trading. Symbotic reported quarterly losses of three cents per share which missed the analyst consensus estimate for losses of two cents. Quarterly revenue of $486.69 million also missed the analyst consensus estimate of $490.98 million.</li>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) fell 12.4% to $0.18 in pre-market trading after dipping 24% on Wednesday. Universe Pharmaceuticals recently announced a Nasdaq delisting notice.</li>
<li>Mach Natural Resources LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) declined 6.9% to $16.00 in pre-market trading as the company announced the launch of 12 million common unit offering.</li>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares dipped 6.1% to $9.40 in pre-market trading. Ford reported upbeat fourth-quarter financial results on Wednesday. Ford said it sees full-year 2025 adjusted EBIT in a range of $7 billion to $8.5 billion, adjusted free cash flow in a range of $3.5 billion to $4.5 billion, and capital spending in a range of $8 billion to $9 billion.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

AVGR

BBAI

DGLY

MBRX

PTIX

RANI

RXRX

SBET

SLXN

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

WIIM

FormFactor shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 guidance below estimates.

B. Riley Securities analyst Craig Ellis downgrades FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) from Buy to Neutral and lowers the price target from $64 to $34.

B. Riley Securities Downgrades FormFactor to Neutral, Lowers Price Target to $34

FormFactor Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) shares are diving in extended trading Wednesday after the company reported fourth-quarter financial results that came up short <a href="https://www.benzinga.com/pressreleases/25/02/g43509179/formfactor-inc-reports-2024-fourth-quarter-results">of analyst expectations</a>.
<ul>
<li>Q4 Revenue: $189.48 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $191.12 million</li>
</ul>
<ul>
<li>Q4 Adjusted EPS: 27 cents, versus estimates of 29 cents</li>
</ul>
Total revenue was up 12.7% on a year-over-year basis. FormFactor said High Bandwidth Memory grew fourfold in fiscal 2024 compared to the prior year, driven by adoption of generative AI. DRAM probe-card revenue&nbsp;continued to climb in the quarter, reaching record levels for the third straight quarter.
&#8220;As expected, FormFactor reported sequentially lower fourth-quarter revenue, gross margin, and non-GAAP earnings per share, driven by the forecasted reduction in Foundry &amp; Logic probe-card revenue,&#8221; said Mike Slessor, CEO of FormFactor. &#8220;This was partially offset by growth in DRAM probe-card revenue, with HBM increasing to approximately half of DRAM revenue.&#8221;
FormFactor also announced that the company and MBK Partners are acquiring FICT Limited from Advantage Partners. FormFactor will invest $60 million and receive a 20% minority stake and a seat on the company&#8217;s board. 
&#8220;FormFactor&#8217;s investment in FICT builds on our long-term collaboration with them as a supplier of the industry-leading, high-performance components we use in our advanced probe cards, and provides a platform for accelerated development of tomorrow&#8217;s test and packaging consumables,&#8221; Slessor added.
See Also: <a href="https://www.benzinga.com/news/earnings/25/02/43511849/strategy-q4-earnings-bitcoin-treasury-company-spends-205b-on-btc-shares-inch-higher-despite-revenue-miss">Strategy Q4 Earnings: Bitcoin Treasury Company Spends $20.5B On BTC, Shares Inch Higher Despite Revenue Miss</a>
Outlook: FormFactor expects first-quarter revenue to be in the range of $165 million to $175 million versus estimates of $195.81 million. The company anticipates first-quarter adjusted earnings of 3 cents to 11 cents per share, versus estimates of 33 cents per share. 
FormFactor noted it has continued to see &#8220;slow demand&#8221; in high-volume markets like client PCs and mobile handsets in the first quarter. Despite the slowing demand, the company anticipates an overall demand increase for its products throughout 2025.
FORM Price Action: FormFactor shares were down 22.81% after hours, trading at $31.74 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using AI from MidJourney.

Earnings

Guidance

After-Hours Center

FormFactor Stock Falls On Q4 Earnings Miss, Weak Guidance As 'Slow Demand' Continues In Q1

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:01 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.04, leading to a 13.0% drop share price change the next day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Q4 Earnings Assessment

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:01 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.04 in the previous quarter, leading to a 13.0% drop share price change the next day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Q4 Earnings Summary & Key Takeaways

The Q4 earnings report for FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) was released on Wednesday, February 5, 2025 at 04:01 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Past Earnings Performance</h3>
During the previous quarter, the company beat on EPS by $0.04, leading to a 13.0% drop share price change the next day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: FormFactor Q4

The earnings results for FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:01 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company beat on EPS by $0.04, resulting in a 13.0% drop change in the share price the following day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Q4 Earnings Report: What Investors Need to Know

With this transaction, FormFactor invests approximately $60M into the consortium. FormFactor will hold a minority, non-controlling stake of 20% and will be granted a seat on the company's board of directors.&nbsp;

FormFactor Reveals Acquisition Of Minority Interest In FICT Limited, A Key Supplier Of Advanced Probe Card Components

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) is looking for Q1 Adj EPS of $0.03-0.11 vs $0.33 analyst estimate. sees sales of $165.000 million-175.000 million vs $195.81 million estimate.

FormFactor Sees Q1 Adj EPS $0.03-0.11 vs $0.33 Est; Sees Sales $165.000M-175.000M vs $195.81M Est

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) is looking for Q1 GAAP EPS of $0.15-0.23 vs $0.23 analyst estimate. sees sales of $165.000 million-175.000 million vs $195.81 million estimate.

FormFactor Sees Q1 GAAP EPS $0.15-0.23 vs $0.23 Est; Sees Sales $165.000M-175.000M vs $195.81M Est

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) released its Q4 earnings on Wednesday, February 5, 2025 at 04:01 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company beat on EPS by $0.04, resulting in a 13.0% drop change in the share price the following day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Earnings Report: Q4 Overview

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.29 by 6.9 percent. This is a 35 percent increase over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $189.48 million which missed the analyst consensus estimate of $191.12 million by 0.86 percent. This is a 12.68 percent increase over sales of $168.16 million the same period last year.

Earnings Misses

FormFactor Q4 Adj EPS $0.27 Misses $0.29 Estimate, Sales $189.48M Miss $191.12M Estimate

FormFactor, Inc. (FORM) Q4 2024 Earnings Call Transcript

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – TTM Technologies&nbsp;(TTMI)&...

Closing Bell Movers: Semis down sharply after results

TD Cowen analyst Krish Sankar has maintained their neutral stance on FORM stock, giving a Hold rating on February 4. Krish Sankar has given his Hol...

Cautious Hold Rating on Formfactor Amid Mixed Signals and Uncertainties

B. Riley downgraded FormFactor (FORM) to Neutral from Buy with a price target of $34, down from $64. The company's Q4 report modestly missed estima...

FormFactor downgraded to Neutral from Buy at B. Riley

In a report released today, Craig Ellis from B.Riley Financial downgraded Formfactor (FORM – Research Report) to a Hold, with a price target of $34...

FormFactor Faces Significant Headwinds Amid Declining Demand and Uncertainty, Hold Rating Recommended

In a report released today, Thomas Diffely from D.A. Davidson reiterated a Buy rating on Formfactor (FORM – Research Report). The company's shares ...

D.A. Davidson Sticks to Their Buy Rating for Formfactor (FORM)

DA Davidson lowered the firm's price target on FormFactor (FORM) to $50 from $55 and keeps a Buy rating on the shares. The firm cites the company's...

FormFactor price target lowered to $50 from $55 at DA Davidson

TD Cowen lowered the firm's price target on FormFactor (FORM) to $35 from $44 and keeps a Hold rating on the shares. The firm said they reported a ...

FormFactor price target lowered to $35 from $44 at TD Cowen

Northland Securities analyst Gus Richard maintained a Hold rating on Formfactor (FORM – Research Report) today and set a price target of $34.00. Th...

Northland Securities Reaffirms Their Hold Rating on Formfactor (FORM)

FormFactor falls following Q4 results, guidance on lackluster PC, smartphone demand

ALGN

AMSC

INTC

KURA

LFVN

NTGR

ORLY

RAMP

TTMI

VKTX

Press Releases

FormFactor to Announce Third Quarter 2024 Financial Results on October 30th

FormFactor, Inc. Reports 2024 Third Quarter Results

General

FormFactor and Advantest Partner on Silicon Photonics Wafer-Level Test Cell to Enable High-Volume Manufacturing

FormFactor Receives SK hynix Best Partner Award

FormFactor Announces Participation at Upcoming Conference

FormFactor Announces Participation in 13th Annual NYC Summit

FormFactor Inc. To Present At The 27th Annual Needham Growth Conference

FormFactor Expands Partnership with Advantest

FormFactor to Announce Fourth Quarter 2024 Financial Results on February 5th

FormFactor, Inc. Reports 2024 Fourth Quarter Results

Axcelis Technologies, Inc. - Common Stock

Axcelis Technologies

ACM Research, Inc. - Class A Common Stock

ACM Research

Aehr Test System

Applied Mat

Amkor Tech

ASML Holding N.V. - New York Registry Shares

ASML Holding

Atomera

Cohu

DAQO New Energy Corp. American Depositary Shares, each representing five ordinary shares

Comments

FormFactor

ニュース

最新ニュース FormFactor (NASDAQ:FORM) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル